Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Non-cash Items: 2019-2021

Historic Non-cash Items for C4 Therapeutics (CCCC) over the last 3 years, with Dec 2021 value amounting to $1.4 million.

  • C4 Therapeutics' Non-cash Items rose 214.00% to $1.7 million in Q1 2022 from the same period last year, while for Mar 2022 it was $1.7 million, marking a year-over-year increase of 214.00%. This contributed to the annual value of $1.4 million for FY2021, which is 199.03% up from last year.
  • As of FY2021, C4 Therapeutics' Non-cash Items stood at $1.4 million, which was up 199.03% from $455,633 recorded in FY2020.
  • Over the past 5 years, C4 Therapeutics' Non-cash Items peaked at $4.8 million during FY2019, and registered a low of $455,633 during FY2020.
  • In the last 3 years, C4 Therapeutics' Non-cash Items had a median value of $1.4 million in 2021 and averaged $2.2 million.
  • Per our database at Business Quant, C4 Therapeutics' Non-cash Items slumped by 90.51% in 2020 and then surged by 199.03% in 2021.
  • Yearly analysis of 3 years shows C4 Therapeutics' Non-cash Items stood at $4.8 million in 2019, then crashed by 90.51% to $455,633 in 2020, then soared by 199.03% to $1.4 million in 2021.